The collaboration between Axxam and Molecular Health focuses on integrating Molecular Health’s Dataome platform with Axxam’s DiscoveryMAXX workflow. Dataome utilizes artificial intelligence to analyze clinical, phenotypic, and molecular datasets, identifying disease-linked targets for potential therapeutics. Axxam then validates these leads using advanced in-vitro systems, including stem cell-based models that mimic human disease biology. This partnership […]
Category: AI-Driven Target Identification
AI-Driven Target Identification in Early Drug Discovery Collaboration
The collaboration between Axxam and Molecular Health focuses on integrating Molecular Health’s Dataome platform with Axxam’s DiscoveryMAXX workflow. Dataome utilizes artificial intelligence to analyze clinical, phenotypic, and molecular datasets, identifying disease-linked targets for potential therapeutics. Axxam then validates these leads using advanced in-vitro systems, including stem cell-based models that mimic human disease biology. This partnership […]
